Aigen Investment Management LP Purchases Shares of 11,524 Bath & Body Works, Inc. (NYSE:BBWI)

Aigen Investment Management LP acquired a new position in Bath & Body Works, Inc. (NYSE:BBWI) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 11,524 shares of the company’s stock, valued at approximately $368,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. First Community Trust NA bought a new stake in Bath & Body Works in the second quarter worth approximately $30,000. Livforsakringsbolaget Skandia Omsesidigt lifted its position in shares of Bath & Body Works by 300.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after acquiring an additional 900 shares during the period. EntryPoint Capital LLC boosted its stake in Bath & Body Works by 224.0% during the first quarter. EntryPoint Capital LLC now owns 1,471 shares of the company’s stock worth $74,000 after acquiring an additional 1,017 shares in the last quarter. GAMMA Investing LLC grew its holdings in Bath & Body Works by 65.4% in the second quarter. GAMMA Investing LLC now owns 1,846 shares of the company’s stock worth $72,000 after purchasing an additional 730 shares during the period. Finally, Blue Trust Inc. increased its stake in Bath & Body Works by 23.4% in the second quarter. Blue Trust Inc. now owns 2,767 shares of the company’s stock valued at $108,000 after purchasing an additional 524 shares in the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Bath & Body Works

In other Bath & Body Works news, CEO Gina Boswell purchased 6,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 9th. The shares were bought at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the purchase, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This represents a 2.53 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.27% of the stock is owned by corporate insiders.

Bath & Body Works Price Performance

Shares of Bath & Body Works stock opened at $31.34 on Friday. The stock has a fifty day moving average price of $30.12 and a 200-day moving average price of $36.60. The firm has a market cap of $6.87 billion, a PE ratio of 7.59, a P/E/G ratio of 1.00 and a beta of 1.79. Bath & Body Works, Inc. has a 1 year low of $26.20 and a 1 year high of $52.99.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.54 billion. As a group, equities analysts anticipate that Bath & Body Works, Inc. will post 3.18 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 22nd will be given a dividend of $0.20 per share. The ex-dividend date is Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.55%. Bath & Body Works’s dividend payout ratio is presently 19.37%.

Analyst Ratings Changes

A number of brokerages recently commented on BBWI. UBS Group decreased their target price on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating for the company in a research report on Thursday, August 29th. JPMorgan Chase & Co. lowered their target price on Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating on the stock in a research report on Thursday, August 29th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Bath & Body Works from $57.00 to $54.00 and set a “buy” rating for the company in a research report on Monday, August 26th. Bank of America lowered their price objective on shares of Bath & Body Works from $54.00 to $45.00 and set a “buy” rating on the stock in a report on Thursday, August 29th. Finally, Telsey Advisory Group reiterated an “outperform” rating and set a $42.00 price objective on shares of Bath & Body Works in a report on Thursday, September 26th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, Bath & Body Works currently has an average rating of “Moderate Buy” and an average target price of $42.44.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.